These results provide pivotal insight into who may be at increased risk for AD neuropathology following TBI and emphasize the importance of studying the genetic pathways associated with AD risk beyond APOE ε4 alone, particularly in the context of TBI. The gene discussed is APOE; the disease is Alzheimer disease.